Cipla
Prasad Deshmukh currently serves as Vice President at Cipla since October 2023 and has extensive experience in the pharmaceutical and healthcare sectors. Prior roles include Vice President, Executive Director, and Senior Director of Safety and Pharmacovigilance at Syneos Health from May 2015 to October 2023. Prior to that, Prasad worked as Senior Manager at Tech Mahindra and Drug Safety Physician at PAREXEL. Additional experience includes a Senior Manager role at Lambda Therapeutic Research and Medical Reviewer at Accenture. Prasad holds an MBBS degree from Govt. Medical College and Hospital, Aurangabad, completed from 1996 to 2002.
This person is not in any teams
Cipla
18 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.